+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Chronic Fatigue Syndrome Treatment Market by Treatment Type (Digital Therapeutics, Non Pharmacological Treatments, Pharmacological Treatments), End User (Ambulatory Care Centers, Home Healthcare, Hospitals), Distribution Channel, Practitioner Type - Global Forecast 2025-2030- Product Image
Chronic Fatigue Syndrome Treatment Market by Treatment Type (Digital Therapeutics, Non Pharmacological Treatments, Pharmacological Treatments), End User (Ambulatory Care Centers, Home Healthcare, Hospitals), Distribution Channel, Practitioner Type - Global Forecast 2025-2030- Product Image
Sale

Chronic Fatigue Syndrome Treatment Market by Treatment Type (Digital Therapeutics, Non Pharmacological Treatments, Pharmacological Treatments), End User (Ambulatory Care Centers, Home Healthcare, Hospitals), Distribution Channel, Practitioner Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010860
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The chronic fatigue syndrome treatment market is undergoing significant transformation, shaped by emerging therapies, advanced technologies, and evolving patient expectations. Senior decision-makers are now navigating a landscape redefined by stakeholder collaboration, regulatory shifts, and the prioritization of patient-centric care.

Market Snapshot: Chronic Fatigue Syndrome Treatment Market

The Chronic Fatigue Syndrome Treatment Market grew from USD 67.93 billion in 2024 to USD 75.75 billion in 2025. This market is projected to sustain momentum with a CAGR of 10.97%, aiming to reach USD 126.88 billion by 2030. Strong growth results from rising awareness of post-viral fatigue, expanding therapeutic options, and increasing patient advocacy. Stakeholder engagement across providers, payers, and industry partners continues to drive changes in care models and supply chain strategies.

Scope & Segmentation

  • Treatment Type
    • Digital Therapeutics: Mobile applications, Telehealth platforms
    • Non Pharmacological Treatments: Alternative therapies, Cognitive behavioral therapy, Graded exercise therapy, Nutritional supplements, Physical therapy
    • Pharmacological Treatments: Analgesics, Antidepressants, Antiviral agents, Immune modulators, Stimulants
  • End User
    • Ambulatory care centers
    • Home healthcare
    • Hospitals
    • Specialty clinics
  • Distribution Channel
    • Hospital pharmacies
    • Online pharmacies
    • Retail pharmacies
  • Practitioner Type
    • Physical therapists
    • Primary care physicians
    • Psychologists
    • Specialists: Immunologists, Neurologists, Rheumatologists
  • Region
    • Americas: United States (California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina
    • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan
  • Leading Companies
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd.
    • Eli Lilly and Company
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd
    • AbbVie Inc.
    • AIM Immunotech Inc.

Key Takeaways

  • Rapid adoption of digital therapeutics is bridging care gaps and enabling scalable patient management, especially in telemedicine and remote monitoring environments.
  • Collaboration among pharmaceutical firms, digital health innovators, and clinical experts is resulting in richer treatment protocols and enhanced patient engagement platforms.
  • Market segmentation by treatment type, care setting, and practitioner specialization allows for more personalized approaches and improved patient outcomes.
  • Patient advocacy and regulatory evolution are redirecting research priorities and accelerating the introduction of multidisciplinary care models.
  • Regional differences require stakeholders to tailor strategies considering local infrastructure, reimbursement ecosystems, and cultural preferences.
  • Outcome-based contracting and integration of real-world data are strengthening value propositions for payers and providers alike.

Tariff Impact

Recent United States tariffs have created complex supply chain challenges for manufacturers and distributors in the chronic fatigue syndrome treatment ecosystem. Changes in sourcing, logistics, and inventory management have influenced procurement decisions and pricing dynamics. Adaptations are underway, such as the forging of new supplier alliances and deployment of advanced analytics to enhance resilience. Strategic focus on local partnerships and agile operations is helping mitigate cost pressures and preserve continuity of care delivery.

Methodology & Data Sources

This report employs a rigorous methodology rooted in in-depth primary interviews and a systematic review of peer-reviewed literature, regulatory filings, and clinical trial registries. Findings were validated with industry experts and adhere to strict data governance and confidentiality standards.

Why This Report Matters

  • Enables executives to align strategy with fast-evolving therapeutic, technological, and regulatory trends within the chronic fatigue syndrome treatment market.
  • Equips stakeholders to anticipate and respond to shifts in patient needs, supply chain pressures, and digital adoption across multiple regions and care segments.
  • Delivers data-driven insights and segmentation analysis to support investment prioritization and partnership decisions in a competitive ecosystem.

Conclusion

The chronic fatigue syndrome treatment market continues to be shaped by innovation, cross-sector collaboration, and agile supply chain responses. Senior leaders can tap into these insights to strengthen positioning and drive patient-centered growth initiatives.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of novel immunomodulatory biologics targeting CFS pathophysiology
5.2. Growing adoption of personalized cognitive-behavioral therapy and graded exercise protocols tailored for chronic fatigue syndrome patients
5.3. Regulatory momentum toward FDA approval of low-dose naltrexone for symptom relief in chronic fatigue syndrome
5.4. Increasing investment in wearable diagnostics for real-time monitoring of fatigue biomarkers in CFS patients
5.5. Rising demand for integrative care models combining nutritional supplements and mind-body interventions for CFS management
5.6. Expansion of telehealth platforms delivering multidisciplinary treatment programs for chronic fatigue syndrome patients
5.7. Advances in genomic and metabolomic profiling to identify subtypes and guide targeted therapies in chronic fatigue syndrome
5.8. Surge in clinical trials assessing antiviral and immunotherapeutic agents for post-viral fatigue syndromes including CFS
5.9. Shift toward patient-centric digital health applications integrating symptom tracking and AI-driven insights for CFS care management
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Chronic Fatigue Syndrome Treatment Market, by Treatment Type
8.1. Introduction
8.2. Digital Therapeutics
8.2.1. Mobile Applications
8.2.2. Telehealth Platforms
8.3. Non Pharmacological Treatments
8.3.1. Alternative Therapies
8.3.2. Cognitive Behavioral Therapy
8.3.3. Graded Exercise Therapy
8.3.4. Nutritional Supplements
8.3.5. Physical Therapy
8.4. Pharmacological Treatments
8.4.1. Analgesics
8.4.2. Antidepressants
8.4.3. Antiviral Agents
8.4.4. Immune Modulators
8.4.5. Stimulants
9. Chronic Fatigue Syndrome Treatment Market, by End User
9.1. Introduction
9.2. Ambulatory Care Centers
9.3. Home Healthcare
9.4. Hospitals
9.5. Specialty Clinics
10. Chronic Fatigue Syndrome Treatment Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. Chronic Fatigue Syndrome Treatment Market, by Practitioner Type
11.1. Introduction
11.2. Physical Therapists
11.3. Primary Care Physicians
11.4. Psychologists
11.5. Specialists
11.5.1. Immunologists
11.5.2. Neurologists
11.5.3. Rheumatologists
12. Americas Chronic Fatigue Syndrome Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Chronic Fatigue Syndrome Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Chronic Fatigue Syndrome Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Pfizer Inc.
15.3.2. GlaxoSmithKline plc
15.3.3. Johnson & Johnson
15.3.4. Novartis AG
15.3.5. Teva Pharmaceutical Industries Ltd.
15.3.6. Eli Lilly and Company
15.3.7. Abbott Laboratories
15.3.8. F. Hoffmann-La Roche Ltd
15.3.9. AbbVie Inc.
15.3.10. AIM Immunotech Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CHRONIC FATIGUE SYNDROME TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CHRONIC FATIGUE SYNDROME TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CHRONIC FATIGUE SYNDROME TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. CHRONIC FATIGUE SYNDROME TREATMENT MARKET: RESEARCHAI
FIGURE 24. CHRONIC FATIGUE SYNDROME TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. CHRONIC FATIGUE SYNDROME TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. CHRONIC FATIGUE SYNDROME TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CHRONIC FATIGUE SYNDROME TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MOBILE APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MOBILE APPLICATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TELEHEALTH PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TELEHEALTH PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY GRADED EXERCISE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY GRADED EXERCISE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ANALGESICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ANTIVIRAL AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ANTIVIRAL AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY IMMUNE MODULATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY IMMUNE MODULATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY STIMULANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY STIMULANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHYSICAL THERAPISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHYSICAL THERAPISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRIMARY CARE PHYSICIANS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRIMARY CARE PHYSICIANS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PSYCHOLOGISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PSYCHOLOGISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY IMMUNOLOGISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY IMMUNOLOGISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NEUROLOGISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NEUROLOGISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY RHEUMATOLOGISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY RHEUMATOLOGISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 119. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 120. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 121. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 122. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 123. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 124. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 125. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 126. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 127. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2025-2030 (USD MILLION)
TABLE 133. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2018-2024 (USD MILLION)
TABLE 134. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2025-2030 (USD MILLION)
TABLE 135. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 136. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 138. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 139. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 140. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 141. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 142. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 143. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2018-2024 (USD MILLION)
TABLE 150. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2025-2030 (USD MILLION)
TABLE 217. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 218. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 219. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 220. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 221. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 222. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 223. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 224. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 225. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2018-2024 (USD MILLION)
TABLE 230. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2025-2030 (USD MILLION)
TABLE 231. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2018-2024 (USD MILLION)
TABLE 232. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2025-2030 (USD MILLION)
TABLE 233. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 234. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 235. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 236. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 237. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 238. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 239. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 240. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 241. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2018-2024 (USD MILLION)
TABLE 246. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2025-2030 (USD MILLION)
TABLE 247. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2018-2024 (USD MILLION)
TABLE 248. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2025-2030 (USD MILLION)
TABLE 265. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 266. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 267. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 268. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 269. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 270. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 271. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 272. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 273. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2018-2024 (USD MILLION)
TABLE 278. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRACTITIONER TYPE, 2025-2030 (USD MILLION)
TABLE 279. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2018-2024 (USD MILLION)
TABLE 280. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SPECIALISTS, 2025-2030 (USD MILLION)
TABLE 281. SPAIN CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREAT

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Chronic Fatigue Syndrome Treatment market report include:
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • AbbVie Inc.
  • AIM Immunotech Inc.

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 75.75 Billion
Forecasted Market Value ( USD ) by 2030 $ 126.88 Billion
Compound Annual Growth Rate10.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Chronic Fatigue Syndrome Treatment MarketReport and Forecast 2024-2032 - Product Image

Chronic Fatigue Syndrome Treatment MarketReport and Forecast 2024-2032

  • Report
  • 250 Pages
  • Global
From
Chronic Fatigue Syndrome Treatment Market Report and Forecast 2024-2032 - Product Image

Chronic Fatigue Syndrome Treatment Market Report and Forecast 2024-2032

  • Report
  • 250 Pages
  • Global
From
Chronic Fatigue Syndrome Therapeutics - Global Strategic Business Report - Product Image

Chronic Fatigue Syndrome Therapeutics - Global Strategic Business Report

  • Report
  • 274 Pages
  • Global
From
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - Pipeline Insight, 2025 - Product Image

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Dysautonomia (Autonomic Dysfunction) Global Market Report 2025 - Product Image

Dysautonomia (Autonomic Dysfunction) Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From

About the Chronic Fatigue Drug Market

The Chronic Fatigue Drug market is a subset of the Central Nervous System Drugs market. It includes drugs used to treat chronic fatigue syndrome (CFS), a condition characterized by extreme fatigue that cannot be explained by any underlying medical condition. These drugs are typically used to reduce fatigue, improve sleep, and increase energy levels. Commonly prescribed drugs include stimulants, antidepressants, and anti-inflammatory medications. The Chronic Fatigue Drug market is highly competitive, with many companies offering products to treat CFS. Some of the major players in the market include GlaxoSmithKline, Pfizer, Merck, Novartis, and Sanofi. Other companies include AbbVie, AstraZeneca, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.